Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

25 Jan 2021

Awakn Appoints James Collins, Ex-Accenture Strategy MD, as Chief Operating Officer

London, United Kingdom–(Newsfile Corp....

By Microdose

Press Releases

25 Jan 2021

Re-Release: Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

22 Jan 2021

Havn Life Grants Stock Options and Restricted Share Rights

Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

22 Jan 2021

Ehave Closes Transaction to Acquire CureDash Assets, Adds KetaDASH Home Delivery Service for Ketamine Clinics

MIAMI, Jan....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

22 Jan 2021

Entheon Biomedical to be Included in First North American Psychedelic ETF

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Press Releases

22 Jan 2021

Numinus Announces Listing of Warrants

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, Jan....

By Microdose

Press Releases

22 Jan 2021

Havn Life Sciences announces inclusion in first psychedelic Exchange Traded Fund

Havn Life is one of a select number of companies that are included in the new ETF Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

21 Jan 2021

Pure Extracts Closes Upsized $8.5 Million Offering With Strong Retail Demand

Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States....

By Microdose

Press Releases

21 Jan 2021

Ehave Revolutionizes Patient Medical Records for Psychedelic Mental Health

Medical records platform for psychedelic mental health to be available February 1 as a Plugin to the Ehave Dashboard....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result